Related Experiment Video
Updated: Jul 11, 2025
11:13
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.6K
Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical
Lokman Varisli1, Garrett M Dancik2, Veysel Tolan1
1Department of Molecular Biology and Genetics, Science Faculty, Dicle University, Diyarbakir 21280, Turkey.
Cancers
|November 14, 2023
Summary
Steroid receptor coactivator-3 (SRC-3) drives breast cancer malignancy by promoting tumor cell behavior, immune suppression, and therapy resistance. Targeting SRC-3 is crucial for effective breast cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Breast cancer (BCa) is a leading cause of cancer death in women, often driven by estrogen signaling.
- Estrogen signaling relies on estrogen receptors and co-regulators like the steroid receptor coactivator (SRC) family.
- SRC-3 amplifies estrogen receptor activity and is implicated in breast cancer progression.
Purpose of the Study:
- To investigate the multifaceted roles of SRC-3 in promoting breast cancer malignancy.
- To explore SRC-3's impact on tumor microenvironment and therapeutic resistance.
- To evaluate SRC-3 as a potential therapeutic target in breast cancer.
Main Methods:
- The study likely involved molecular and cellular biology techniques to analyze SRC-3 expression and function in breast cancer models.
- Investigated SRC-3's interaction with estrogen receptors and its effect on gene transcription.
- Assessed SRC-3's influence on tumor cell behavior, immune cell infiltration, and response to therapies.
Main Results:
- SRC-3 overexpression is linked to enhanced malignant behaviors in breast cancer cells.
- SRC-3 contributes to an immunosuppressive tumor microenvironment, hindering anti-tumor immunity.
- SRC-3 promotes cancer stemness and resistance to hormone therapy and immunotherapy.
Conclusions:
- SRC-3 is a versatile driver of breast cancer malignancy through diverse mechanisms.
- Targeting SRC-3 presents a promising strategy to overcome treatment resistance and improve patient outcomes.
- Further research into SRC-3 inhibition is warranted for novel breast cancer therapies.
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K